SUBSCRIBE
SUBSCRIBE
News   Policy

Novartis AG Officials Hid Bone Drugs’ Risks, Lawyer Tells Jurors

November 2, 2010 | 
1 min read
Bloomberg -- Novartis AG officials downplayed risks that the drugmaker’s bone-strengthening medicines Aredia and Zometa could destroy patients’ jaws, a lawyer for a woman suing the company told a North Carolina jury.
Legal Europe
Novartis
MORE ON THIS TOPIC
Approved and confirmed document file with check mark icon flat cartoon, concept of agreement or contract symbol with checkmark, accepted or certified license paper form pictogram isolated image
Manufacturing
Eli Lilly and Regeneron among 7 companies picked for FDA PreCheck pilot program
July 1, 2026
 · 
2 min read
 · 
Nick Paul Taylor
A man and woman on opposite edges of a large chat bubble
Insights
Golden Triangle still dominates, but talent and capital gaps slow biotech growth
July 1, 2026
 · 
3 min read
 · 
Jennifer C. Smith-Parker
Plan to buying new house or renovation, mortgage loan or housing expense, property maintenance or real estate insurance concept, smart businessman put jigsaw to complete or finishing house puzzle.
FDA
BIO 2026: FDA’s IND initiative is a step toward normalization after slipshod year
June 25, 2026
 · 
3 min read
 · 
Jef Akst
Insights
The Golden Triangle and the gaps: Rethinking UK biotech
June 25, 2026
 · 
1 min read
 · 
Jennifer C. Smith-Parker